LEADER 01232nam0 2200301 i 450 
001 VAN0114168
005 20230405110329.884
017 70$2N$a978-3-642-54562-7
100   $a20180130d2014       |0itac50      ba
101   $aeng
102   $aDE
105   $a||||    |||||
200 1 $aPsychopharmacology and Pregnancy$eTreatment Efficacy, Risks, and Guidelines$fMegan Galbally, Martien Snellen, Andrew Lewis, Editors
210   $aHeidelberg$cSpringer$d2014
215   $aVI, 232 p.$d23 cm
620   $aDE$dHeidelberg$3VANL000282
702  1$aGalbally$bMegan$3VANV088265
702  1$aLewis$bAndrew$3VANV088267
702  1$aSnellen$bMartien$3VANV088266
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20240614$gRICA
856 4 $uhttps://link.springer.com/book/10.1007%2F978-3-642-54562-7$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN0114168
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 2002                      $e15EB 2002              20180130            
996   $aPsychopharmacology and Pregnancy$91522997
997   $aUNICAMPANIA